Strengths of the French end-of-life Law as Well as its Shortcomings in Handling Intractable Disputes Between Physicians and Families.
End-of-life
intensive care
legal inquiry
treatment withdrawal
unreasonable obstinacy
Journal
The New bioethics : a multidisciplinary journal of biotechnology and the body
ISSN: 2050-2885
Titre abrégé: New Bioeth
Pays: England
ID NLM: 101627814
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
18
2
2020
medline:
11
11
2020
entrez:
18
2
2020
Statut:
ppublish
Résumé
French end-of-life law aims at protecting patients from unreasonable treatments, but has been used to force caregivers to prolong treatments deemed unreasonable. We describe six cases (five intensive care unit patients including two children) where families disagreed with a decision to withdraw treatments and sued medical teams. An emergent inquiry was instigated by the families. In two cases, the court rejected the families' inquiries. In two cases, the families appealed the decision, and in both the first jurisdiction decision was confirmed, compelling caregivers to pursue treatments, even though they deemed them unreasonable. We discuss how this law may be perverted. Legal procedures may result in the units' disorganisation and give rise to caregivers' stress. Families' requests may be subtended by religious beliefs. French end-of-life law has benefits in theoretically constraining physicians to withhold or withdraw disproportionate therapies. These cases underline some caveats and the perverse effects of its literal reading.
Identifiants
pubmed: 32065064
doi: 10.1080/20502877.2020.1720421
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM